Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review-Reference-Cited by-同舟云学术

Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review

Published:2020-07-27 Issue:4 Volume:21 Page:655-666
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Al-Ziftawi Nour Hisham¹,Shafie Asrul Akmal²³^ORCID,Mohamed Ibrahim Mohamed Izham¹^ORCID

Affiliation:

1. Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, Doha, Qatar

2. Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

3. Institutional Planning and Strategic Center, Universiti Sains Malaysia, Penang, Malaysia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1794826

Reference52 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

3. Breast cancer statistics. Cancer research UK . cited 2019 Apr 29. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer

4. Comparing more and less developed countries. World cancer research fund . cited 2019 Apr 29. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/comparing-more-and-less-developed-countries

5. Addressing Cancer Drug Costs and Value - National Cancer Institute . cited 2019 Apr 29. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2018/presidents-cancer-panel-drug-prices

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Most systematic reviews reporting adherence to AMSTAR 2 had critically low methodological quality: a cross-sectional meta-research study;Journal of Clinical Epidemiology;2024-01

2. A systematic literature review on direct and indirect costs of triple-negative breast cancer;Cost Effectiveness and Resource Allocation;2023-11-30

3. Histopathological breast cancer classification using CNN;Materials Today: Proceedings;2023-11

4. Real-World Evidence of Biosimilar Utilisation and Pharmacoeconomics in People Living with Breast or Lung Cancer;EMJ Oncology;2023-10-02

5. Real-World Evidence of Biosimilar Utilisation and Pharmacoeconomics in People Living with Breast or Lung Cancer;EMJ Oncology;2023-10-02